GlassScriptPhysician profile
Joshua M Henry
NPI 1710301205
$4,020.07
in general payments reported to CMS, 2019-2025
44 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $628 · 2021: $2,070 · 2022: $390 · 2023: $320 · 2024: $94.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $414.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genesys Orthopedics Systems, L.L.C. | $500.43 | 2021 | |
| Collegium Pharmaceutical, INC. | $335.01 | 2019-2022 | |
| Stimwave Technologies Incorporated | $315.08 | 2020-2022 | |
| Medtronic, INC. | $284.77 | 2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $263.35 | 2020-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $255.80 | 2019-2022 | |
| Abbvie INC. | $175.44 | 2021-2022 | |
| Amgen INC. | $171.41 | 2019-2021 | |
| Allergan, INC. | $153.99 | 2019-2021 | |
| Novo Nordisk INC | $124.91 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $121.42 | 2021 | |
| Biodelivery Sciences International, INC. | $118.68 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $114.24 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $97.31 | 2019 | |
| Flowonix Medical Incorporated | $86.99 | 2019-2020 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.